In addition, the expression of E2F2 in pancreatic cancer cells interfered with gemcitabine was increased, and the expression of gemcitabine resistance gene RRM2 and its downstream DCK were up-regulated in pancreatic cancer cells by the high expression of E2F2, and the resistance of pancreatic cancer cells to gemcitabine was enhanced in vitro and in vivo .
正在翻译中..